Skip to main content
Log in

Assessment of myosteatosis and functionality in pretreatment gynecological cancer patients

  • Research
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Purpose

We aimed to investigate the relationship between pretreatment gynecologic cancer survival and the physical function of patients with myosteatosis. Understanding this relationship prior to treatment would help healthcare providers identify and refer patients with poor muscle quality to an exercise program prior to treatment.

Methods

We conducted a cross-sectional analysis of 73 GC patients. Physical function was quantified using handgrip strength and an adapted version of the Senior Fitness Test (aerobic endurance not included). The EORTC QLC-C30 was used to evaluate general health quality. Myosteatosis (values below the median muscle radiodensity), muscle mass, and adipose tissue variables were calculated from the computed tomography (CT) scan at the third lumbar vertebra using specific software.

Results

Seventy patients (50.9 ± 15.2) were included; 41.5% had stage III or IV disease, and 61.4% had cervical cancer. The myosteatosis group was 11.9 years older and showed reduced functioning compared to the normal-radiodensity group. Age and Timed Up and Go (TUG) test results were shown to be the most reliable predictors of muscle radiodensity in pretreatment gynecological patients according to multivariate regression analysis (R2 = 0.314).

Conclusion

Gynecological healthcare professionals should be aware that prompt exercise programs might be especially beneficial for older patients with reduced TUG performance to preserve muscle function and quality.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Data Availability

No datasets were generated or analysed during the current study.

References

  1. Correa-de-Araujo R, Addison O, Miljkovic I et al (2020) Myosteatosis in the context of skeletal muscle function deficit: an interdisciplinary workshop at the national institute on aging. Front Physiol 11:963. https://doi.org/10.3389/fphys.2020.00963

    Article  PubMed  PubMed Central  Google Scholar 

  2. Arteaga DP, DeKraker C, Ennis M et al (2023) Body composition and endometrial cancer outcomes. J Natl Cancer Inst Monogr 2023:49–55. https://doi.org/10.1093/jncimonographs/lgad012

    Article  PubMed  Google Scholar 

  3. Rodrigues CS, Chaves GV (2018) Skeletal muscle quality beyond average muscle attenuation: a proposal of skeletal muscle phenotypes to predict short-term survival in endometrial cancer patients. J Natl Compr Canc Netw 16. https://doi.org/10.6004/jnccn.2017.7028

  4. Weng C, Huang W, Chang C et al (2023) Association of malignant ascites with systemic inflammation and muscle loss after treatment in advanced-stage ovarian cancer. J Cachexia Sarcopenia Muscle 14:2114–2125. https://doi.org/10.1002/jcsm.13289

    Article  PubMed  PubMed Central  Google Scholar 

  5. Polen-De C, Fadadu P, Weaver AL et al (2022) Quality is more important than quantity: pre-operative sarcopenia is associated with poor survival in advanced ovarian cancer. Int J Gynecol Cancer 32:1289–1296. https://doi.org/10.1136/ijgc-2022-003387

    Article  Google Scholar 

  6. Lee J, Lin J-B, Wu M-H et al (2019) Muscle radiodensity loss during cancer therapy is predictive for poor survival in advanced endometrial cancer. J Cachexia Sarcopenia Muscle 10:814–826. https://doi.org/10.1002/jcsm.12440

    Article  PubMed  PubMed Central  Google Scholar 

  7. Stretch C, Aubin J-M, Mickiewicz B et al (2018) Sarcopenia and myosteatosis are accompanied by distinct biological profiles in patients with pancreatic and periampullary adenocarcinomas. PLoS One 13:e0196235. https://doi.org/10.1371/journal.pone.0196235

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Cao H, Gong Y, Wang Y (2022) The prognostic impact of myosteatosis on overall survival in gynecological cancer patients: a meta-analysis and trial sequential analysis. Int J Cancer 151:1997–2003. https://doi.org/10.1002/ijc.34179

    Article  CAS  PubMed  Google Scholar 

  9. Aleixo GFP, Shachar SS, Nyrop KA et al (2019) Myosteatosis and prognosis in cancer: systematic review and meta-analysis. Crit Rev Oncol Hematol 145:102839. https://doi.org/10.1016/j.critrevonc.2019.102839

    Article  PubMed  Google Scholar 

  10. West MA, van Dijk DPJ, Gleadowe F et al (2019) Myosteatosis is associated with poor physical fitness in patients undergoing hepatopancreatobiliary surgery. J Cachexia Sarcopenia Muscle 10:860–871. https://doi.org/10.1002/jcsm.12433

    Article  PubMed  PubMed Central  Google Scholar 

  11. Shaver AL, Noyes K, Platek ME et al (2022) Cross-sectional analysis of myosteatosis and physical function in pretreatment head and neck cancer patients. Support Care Cancer 30:3401–3408. https://doi.org/10.1007/s00520-022-06808-x

    Article  PubMed  PubMed Central  Google Scholar 

  12. Costa GBC, Carneiro G, Umeda L et al (2020) Influence of menopausal hormone therapy on body composition and metabolic parameters. Biores Open Access 9:80–85. https://doi.org/10.1089/biores.2019.0050

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Musoro JZ, Coens C, Sprangers MAG et al (2023) Minimally important differences for interpreting EORTC QLQ-C30 change scores over time: a synthesis across 21 clinical trials involving nine different cancer types. Eur J Cancer 188:171–182. https://doi.org/10.1016/j.ejca.2023.04.027

    Article  PubMed  Google Scholar 

  14. Jin Y, Ma X, Yang Z, Zhang N (2023) Low L3 skeletal muscle index associated with the clinicopathological characteristics and prognosis of ovarian cancer: a meta-analysis. J Cachexia Sarcopenia Muscle 14:697–705. https://doi.org/10.1002/jcsm.13175

    Article  PubMed  PubMed Central  Google Scholar 

  15. Sasani K, Catanese HN, Ghods A et al (2019) Gait speed and survival of older surgical patient with cancer: prediction after machine learning. J Geriatr Oncol 10:120–125. https://doi.org/10.1016/j.jgo.2018.06.012

    Article  PubMed  Google Scholar 

  16. Aubrey J, Esfandiari N, Baracos VE et al (2014) Measurement of skeletal muscle radiation attenuation and basis of its biological variation. Acta Physiol (Oxf) 210:489–497. https://doi.org/10.1111/apha.12224

    Article  CAS  PubMed  Google Scholar 

  17. Aleixo GFP, Deal AM, Nyrop KA et al (2020) Association of body composition with function in women with early breast cancer. Breast Cancer Res Treat 181:411–421. https://doi.org/10.1007/s10549-020-05624-3

    Article  CAS  PubMed  Google Scholar 

  18. Roberts HC, Denison HJ, Martin HJ et al (2011) A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. Age Ageing 40:423–429. https://doi.org/10.1093/ageing/afr051

    Article  PubMed  Google Scholar 

  19. Kilgour RD, Vigano A, Trutschnigg B et al (2013) Handgrip strength predicts survival and is associated with markers of clinical and functional outcomes in advanced cancer patients. Support Care Cancer 21:3261–3270. https://doi.org/10.1007/s00520-013-1894-4

    Article  CAS  PubMed  Google Scholar 

  20. López-Bueno R, Andersen LL, Koyanagi A et al (2022) Thresholds of handgrip strength for all-cause, cancer, and cardiovascular mortality: a systematic review with dose-response meta-analysis. Ageing Res Rev 82:101778. https://doi.org/10.1016/j.arr.2022.101778

    Article  PubMed  Google Scholar 

  21. Rikli RE, Jones JC (2001) Senior fitness test manual, Human Kinetics, Champaign, IL.

  22. Jones JC, Rikli RE (2002) Measuring functional. J Active Aging 1: 24–30. https://www.medicina.univr.it/documenti/OccorrenzaIns/matdid/matdid182478.pdf

  23. Crawford JJ, Vallance JK, Holt NL et al (2017) A pilot randomized, controlled trial of a wall climbing intervention for gynecologic cancer survivors. Oncol Nurs Forum 44:77–86. https://doi.org/10.1188/17.ONF.77-86

    Article  PubMed  Google Scholar 

  24. Maréchal R, Fontvieille A, Parent-Roberge H et al (2019) Effect of a mixed-exercise program on physical capacity and sedentary behavior in older adults during cancer treatments. Aging Clin Exp Res 31:1583–1589. https://doi.org/10.1007/s40520-018-1097-4

    Article  PubMed  Google Scholar 

  25. Podsiadlo D, Richardson S (1991) The timed “Up & Go”: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 39:142–148. https://doi.org/10.1111/j.1532-5415.1991.tb01616.x

    Article  CAS  PubMed  Google Scholar 

  26. Brown JC, Harhay MO, Harhay MN (2015) Physical function as a prognostic biomarker among cancer survivors. Br J Cancer 112:194–198. https://doi.org/10.1038/bjc.2014.568

    Article  CAS  PubMed  Google Scholar 

  27. Wang Y, Tian G, Chen S, Li N (2021) Myosteatosis reduces overall survival in patients with digestive system malignancies: a meta-analysis with trial sequential analysis. Nutr Res 94:25–33. https://doi.org/10.1016/j.nutres.2021.08.003

    Article  CAS  PubMed  Google Scholar 

  28. Frank-Wilson AW, Farthing JP, Chilibeck PD et al (2016) Lower leg muscle density is independently associated with fall status in community-dwelling older adults. Osteoporos Int 27:2231–2240. https://doi.org/10.1007/s00198-016-3514-x

    Article  CAS  PubMed  Google Scholar 

  29. Benavent-Caballer V, Sendin-Magdalena A, Lison JF et al (2016) Physical factors underlying the Timed “Up and Go” test in older adults. Geriatr Nurs 37:122–127. https://doi.org/10.1016/j.gerinurse.2015.11.002

    Article  PubMed  Google Scholar 

  30. Verweij NM, Schiphorst AH, Pronk A et al (2016) Physical performance measures for predicting outcome in cancer patients: a systematic review. Acta Oncol 55:1386–1391. https://doi.org/10.1080/0284186x.2016.1219047

    Article  PubMed  Google Scholar 

  31. Sanders DB, Guptill JT, Aleš KL et al (2017) Reliability of the triple-timed up-and-go test. Muscle Nerve 57:136–139. https://doi.org/10.1002/mus.25700

    Article  PubMed  PubMed Central  Google Scholar 

  32. Graff K, Szczerbik E, Kalinowska M et al (2022) Using the TUG test for the functional assessment of patients with selected disorders. Int J Environ Res Public Health 19. https://doi.org/10.3390/ijerph19084602

  33. Miljkovic I, Kuipers AL, Cvejkus R et al (2015) Myosteatosis increases with aging and is associated with incident diabetes in African ancestry men. Obesity (Silver Spring) 24:476–482. https://doi.org/10.1002/oby.21328

    Article  CAS  PubMed  Google Scholar 

  34. Pedersen BK (2011) Exercise-induced myokines and their role in chronic diseases. Brain Behav Immun 25:811–816. https://doi.org/10.1016/j.bbi.2011.02.010

    Article  CAS  PubMed  Google Scholar 

  35. Ahima RS, Park HK (2015) Connecting myokines and metabolism. Endocrinol Metab (Seoul) 30:235–245. https://doi.org/10.3803/EnM.2015.30.3.235

    Article  CAS  PubMed  Google Scholar 

  36. Amini B, Boyle SP, Boutin RD, Lenchik L (2019) Approaches to assessment of muscle mass and myosteatosis on computed tomography: a systematic review. J Gerontol A Biol Sci Med Sci 74:1671–1678. https://doi.org/10.1093/gerona/glz034

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We appreciate the participation and technical assistance of the entire hospital staff.

Author information

Authors and Affiliations

Authors

Contributions

RCS wrote the manuscript, acquired the data, and contributed to the analysis and interpretation of the data and critical revision. GVC contributed to the study conception and design, acquired the data, and contributed to the analysis and interpretation of the data and critical revision. AB contributed to the study conception and design, contributed to the analysis and interpretation of the data, and contributed to critical revision. FTF wrote the manuscript, contributed to the study conception and design, contributed to the analysis and interpretation of the data, and contributed to critical revision.

Corresponding author

Correspondence to Fernando Tadeu Trevisan Frajacomo.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 30 KB)

Supplementary file2 (PDF 26 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

da Silva, R.C., Chaves, G.V., Bergmann, A. et al. Assessment of myosteatosis and functionality in pretreatment gynecological cancer patients. Support Care Cancer 32, 339 (2024). https://doi.org/10.1007/s00520-024-08558-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00520-024-08558-4

Keywords

Navigation